Markets.News

TBPH  THERAVANCE BIOPHARMA INC

+ add to watchlist

$18.43

theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.

Mkt Cap: $933.89M

52 Week High: $20.33

P/E: -8.84

52 Week Low: $7.90

Dividend: $0.00

Shares Outstanding: 50.67M

This news is delayed by 15 minutes, sign up now to get live news & full features.